Cover Image
市場調查報告書

KAHR medical Ltd.:產品平台分析

KAHR medical Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253800
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
KAHR medical Ltd.:產品平台分析 KAHR medical Ltd. - Product Pipeline Review - 2015
出版日期: 2015年07月15日 內容資訊: 英文 21 Pages
簡介

KAHR medical Ltd.是致力於開發治療癌症及自體免疫疾病所用的融合蛋白醫藥品之製藥公司。

本報告提供KAHR medical Ltd.的產品開發平台現狀及各開發階段比較分析,提供您藥物簡介,開發平台的分析與最新趨勢,暫停中的計劃等資訊。

KAHR medical Ltd.的基本資料

KAHR medical Ltd.概要

  • 主要資訊
  • 企業資料

KAHR medical Ltd.:R&D概要

  • 主要的治療範圍

KAHR medical Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

KAHR medical Ltd.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

KAHR medical Ltd.:藥物簡介

  • KAHR-101
  • KAHR-102
  • KAHR-103

KAHR medical Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

KAHR medical Ltd.:最近的開發平台趨勢

KAHR medical Ltd.:暫停中的計劃

KAHR medical Ltd.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07322CDB

Summary

Global Markets Direct's, 'KAHR medical Ltd. - Product Pipeline Review - 2015', provides an overview of the KAHR medical Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of KAHR medical Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of KAHR medical Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of KAHR medical Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the KAHR medical Ltd.'s pipeline products

Reasons to buy

  • Evaluate KAHR medical Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of KAHR medical Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the KAHR medical Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of KAHR medical Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of KAHR medical Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of KAHR medical Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • KAHR medical Ltd. Snapshot
    • KAHR medical Ltd. Overview
    • Key Information
    • Key Facts
  • KAHR medical Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • KAHR medical Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • KAHR medical Ltd. - Pipeline Products Glance
    • KAHR medical Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • KAHR medical Ltd. - Drug Profiles
    • KAHR-101
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • KAHR-102
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • KAHR-103
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • KAHR medical Ltd. - Pipeline Analysis
    • KAHR medical Ltd. - Pipeline Products by Target
    • KAHR medical Ltd. - Pipeline Products by Route of Administration
    • KAHR medical Ltd. - Pipeline Products by Molecule Type
    • KAHR medical Ltd. - Pipeline Products by Mechanism of Action
  • KAHR medical Ltd. - Recent Pipeline Updates
  • KAHR medical Ltd. - Dormant Projects
  • KAHR medical Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • KAHR medical Ltd., Key Information
  • KAHR medical Ltd., Key Facts
  • KAHR medical Ltd. - Pipeline by Indication, 2015
  • KAHR medical Ltd. - Pipeline by Stage of Development, 2015
  • KAHR medical Ltd. - Monotherapy Products in Pipeline, 2015
  • KAHR medical Ltd. - Preclinical, 2015
  • KAHR medical Ltd. - Pipeline by Target, 2015
  • KAHR medical Ltd. - Pipeline by Route of Administration, 2015
  • KAHR medical Ltd. - Pipeline by Molecule Type, 2015
  • KAHR medical Ltd. - Pipeline Products by Mechanism of Action, 2015
  • KAHR medical Ltd. - Recent Pipeline Updates, 2015
  • KAHR medical Ltd. - Dormant Developmental Projects,2015

List of Figures

  • KAHR medical Ltd. - Pipeline by Top 10 Indication, 2015
  • KAHR medical Ltd. - Pipeline by Top 10 Target, 2015
  • KAHR medical Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top